5-AMINO-5-DEOXY-GLUCOPYRANOSE BISULFITE
![]() |
- $241 - $1778.7
- Product name: 5-AMINO-5-DEOXY-GLUCOPYRANOSE BISULFITE
- CAS: 81703-56-2
- MF: C6H13NO7S
- MW: 243.23
- EINECS:687-810-3
- MDL Number:MFCD01630888
- Synonyms:5-AMINO-5-DEOXY-GLUCOPYRANOSE BISULFITE;NOJIRIMYCIN BISULFITE;Nojirimycin bisulfite microbial;(2S,3R,4S,5R,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)-2-piperidinesulfonic acid;2-Piperidinesulfonic acid, 3,4,5-trihydroxy-6-(hydroxymethyl)-, (2S,3R,4S,5R,6R)-
3 prices
Selected condition:
Brand
- American Custom Chemicals Corporation
- Sigma-Aldrich
Package
- 5mg
- 10MG
- 100MG
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberINB0001195
- Product descriptionNOJIRIMYCIN BISULFITE MICROBIAL 95.00%
- Packaging10MG
- Price$727.65
- Updated2021-12-16
- Buy
- ManufacturerAmerican Custom Chemicals Corporation
- Product numberINB0001195
- Product descriptionNOJIRIMYCIN BISULFITE MICROBIAL 95.00%
- Packaging100MG
- Price$1778.7
- Updated2021-12-16
- Buy
- ManufacturerSigma-Aldrich
- Product numberN7779
- Product descriptionNojirimycin bisulfite microbial solid
- Packaging5mg
- Price$241
- Updated2024-03-01
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
American Custom Chemicals Corporation | INB0001195 | NOJIRIMYCIN BISULFITE MICROBIAL 95.00% | 10MG | $727.65 | 2021-12-16 | Buy |
American Custom Chemicals Corporation | INB0001195 | NOJIRIMYCIN BISULFITE MICROBIAL 95.00% | 100MG | $1778.7 | 2021-12-16 | Buy |
Sigma-Aldrich | N7779 | Nojirimycin bisulfite microbial solid | 5mg | $241 | 2024-03-01 | Buy |
Properties
Density :1.89±0.1 g/cm3(Predicted)
storage temp. :−20°C
form :solid
pka :-1.21±0.70(Predicted)
storage temp. :−20°C
form :solid
pka :-1.21±0.70(Predicted)
Safety Information
Symbol(GHS): |
![]() |
||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||||||||||||||||
Hazard statements: |
|
||||||||||||||||||||||||||||
Precautionary statements: |
|